Sibs of affected individuals should be identified either through molecular genetic testing of IDUA, if both pathogenic variants in the family are known, or assay of IDUA enzyme activity in order to initiate therapy as early in the course of disease as possible.

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.

Pregnancy Management

Key elements of the management of women with MPS I who become pregnant involve assessment and frequent monitoring of cardiorespiratory as well as spinal cord involvement.
